Inogen (INGN) Change in Receivables (2013 - 2026)
Inogen (INGN) reported Change in Receivables of $5.5 million for Q1 2026, down 32.79% year-over-year from $8.2 million in Q1 2025, and up 5534.65% quarter-over-quarter from -$101000.0 in Q4 2025.
Inogen (INGN) Change in Receivables (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Change in Receivables data on file, last reported at $5.5 million in Q1 2026.
- Change in Receivables for Q1 2026 came in at $5.5 million, down 32.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.9 million (down 8.72% YoY), and the FY2025 annual result was $14.6 million, up 181.94% from the prior year.
- Change in Receivables grew to $5.5 million in Q1 2026 per INGN's latest filing, from -$101000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $24.0 million in Q3 2022 and troughed at -$6.7 million in Q1 2023.
- A 5-year average of $3.9 million and a median of $2.6 million in 2024 frame the typical range for Change in Receivables.
- On a YoY basis, Change in Receivables climbed as much as 51080.0% in 2024 and fell as far as 299.05% in 2024.
- A 5-year view of Change in Receivables shows it stood at $13.5 million in 2022, then tumbled by 122.21% to -$3.0 million in 2023, then surged by 234.39% to $4.0 million in 2024, then tumbled by 102.5% to -$101000.0 in 2025, then jumped by 5534.65% to $5.5 million in 2026.
- Business Quant data shows INGN's Change in Receivables at $5.5 million in Q1 2026, -$101000.0 in Q4 2025, and $3.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn | 5.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.49 Mn |
| Mar 31, 2026 | 5.49 Mn |
| Dec 31, 2025 | -101,000.00 |
| Dec 31, 2025 | -101,000.00 |
| Sep 30, 2025 | 3.69 Mn |
| Sep 30, 2025 | 3.69 Mn |
| Jun 30, 2025 | 2.87 Mn |
| Jun 30, 2025 | 2.87 Mn |
| Mar 31, 2025 | 8.17 Mn |
| Mar 31, 2025 | 8.17 Mn |
| Dec 31, 2024 | 4.03 Mn |
| Dec 31, 2024 | 4.03 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Jun 30, 2024 | -1.67 Mn |
| Jun 30, 2024 | -1.67 Mn |
| Mar 31, 2024 | 267,000.00 |
| Mar 31, 2024 | 267,000.00 |
| Dec 31, 2023 | -3.00 Mn |
| Dec 31, 2023 | -3.00 Mn |